alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 401.140 Fees and charges. ( a ) *Statement of policy.* It is CMS's policy to comply with certain requests for information services without charge. Except as otherwise determined pursuant to paragraph (c) of this section, fees will be charged for the following services with respect to all other requests for information from records which are reasonably identified by the requesters: ( 1 ) Reproduction, duplication, or copying of records;
( 2 ) Searches for records; and
( 3 ) Certification or authentication of records.
( b ) *Fee schedules.* The fee schedule is as follows: ( 1 ) *Search for records.* Three dollars per hour: *Provided, however,* That no charge will be made for the first half hour.
( 2 ) *Reproduction, duplication, or copying of records.* Ten cents per page where such reproduction can be made by commonly available photocopying machines. The cost of reproducing records which cannot be so photocopied will be determined on an individual basis at actual cost.
( 3 ) *Certification or authentication of records.* Three dollars per certification or authentication.
( 4 ) *Forwarding materials to destination.* Any special arrangements for forwarding which are requested shall be charged at actual cost; however, no charge will be made for postage.
( 5 ) No charge will be made when the total amount does not exceed five dollars.
( c ) *Waiver or reduction of fees.* Waiver or reduction of the fees in paragraph (b) of this section may be made upon a determination that such waiver or reduction is in the public interest because furnishing the information can be considered as primarily benefiting the general public. Such determination may be made by the appropriate officer or employee identified in § 401.144.
( d ) *Sale of documents.* On occasion, a previously printed document may be available for sale to the public; the cost of supplying the document is one cent per page unless the document is available for sale from the Superintendent of Documents, in which case the price shall be that determined by the Superintendent.
|   | (1) | The      Report fully complies with the requirements of section 13(a) or 15(d) of      the Securities Exchange Act of 1934;and |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of the      Company. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:  November 16, 2009                                                          |   |   |   |
|----------------------------------------------------------------------------------------|--------|--------|--------|
|                                                                                   |   |   |   |
| /s/      Christopher R. Miller                                          |   |   |   |
|                                                                                        |   |   |   |
| Christopher R. MillerChief      Financial OfficerInMedica      Development Corporation |   |   |   |
|                                                                                   |   |   |   |

----
Exhibit
32





CERTIFICATION


PURSUANT
TO 18 U.S.C. SECTION 1350


AS
ADOPTED PURSUANT TO SECTION 906 OF THE


SARBANES-OXLEY
ACT OF 2002





In
connection with the Quarterly Report of First Community Bancshares, Inc. (the
“Company”) on Form 10-Q for the period ended March 31, 2010, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), the
undersigned hereby certify, to the officers’ best knowledge and belief, pursuant
to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the
Sarbanes-Oxley Act of 2002:





(a) the
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and





(b) the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





Dated
this 7th day of
May, 2010.





First
      Community Bancshares, Inc./s/ John M. MendezJohn
      M. MendezChief
      Executive Officer/s/ David D. BrownDavid
      D. BrownChief
      Financial Officer
Exhibit 31.1**CERTIFICATION**I, C. Jayson Brentlinger, certify that:1. I have reviewed this Report on Form 10-QSB of Circuit Research Labs, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, ismade known to us by others within those entities, particularly during the period inwhich this report is being prepared;  (c) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluation; and  (d) Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions):
 

 
 (a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize and reportfinancial information; and  (b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control overfinancial reporting.Date: November 21, 2005./s/ C. Jayson Brentlinger
[Federal Register Volume 74, Number 167 (Monday, August 31, 2009)]
[Notices]
[Page 44860]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-20877]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Cancer Institute Clinical Trials and Translational Research 
Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Clinical Trials and 
Translational Research Advisory Committee.
    Date: November 4, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: Update on the progress of the implementation of the 
Clinical Trials Working Group and the Translational Research Working 
Group reports.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Bethesda, MD 20892.
    Contact Person: Sheila A. Prindiville, MD, MPH, Director, 
Coordinating Center for Clinical Trials, Office of the Director, 
National Cancer Institute, National Institutes of Health, 6120 
Executive Blvd., 3rd Floor Suite, Bethesda, MD 20892, 301-451-5048, 
<a href="/cdn-cgi/l/email-protection#fe8e8c97909a97888dbe939f9792d0909796d0999188"><span class="__cf_email__" data-cfemail="d2a2a0bbbcb6bba4a192bfb3bbbefcbcbbbafcb5bda4">[email protected]</span></a>.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-20877 Filed 8-28-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2005271EN.01000901.xml

| 29.10.2005 | EN | Official Journal of the European Union | C 271/9 |
| --- | --- | --- | --- |

29.10.2005

EN

Official Journal of the European Union

C 271/9

---

JUDGMENT OF THE COURT

JUDGMENT OF THE COURT

(First Chamber)

of 8 September 2005

in Case C-288/04, Reference for a preliminary ruling from the Unabhängiger Finanzsenat, Außenstelle Wien, AB v Finanzamt für den 6., 7. und 15. Bezirk (1)

1

(Protocol on the Privileges and Immunities of the European Communities - Staff regulations - Conditions of employment applicable to other servants - Local member of staff at the representation of the Commission in Austria - Tax treatment)

(2005/C 271/16)

Language of the case: German

In Case C-288/04: reference for a preliminary ruling under Article 234 EC from the Unabhängiger Finanzsenat, Außenstelle Wien (Austria), made by decision of 28 June 2004, received at the Court on 6 July 2004, in the proceedings between AB and Finanzamt für den 6., 7. und 15. Bezirk — the Court (First Chamber) composed of P. Jann, President of the Chamber, K. Lenaerts, K. Schiemann, E. Juhász (Rapporteur) and M. Ilešič, Judges; L.A. Geelhoed, Advocate General; R. Grass, Registrar, gave a judgment on 8 September 2005, the operative part of which is as follows:

For the purposes of applying Articles 13 and 16 of the Protocol on the Privileges and Immunities of the European Communities, the decision of a Community institution defining the status of one of its servants and determining his conditions of employment is binding on national judicial and administrative authorities, so that they cannot make an independent classification of the employment relationship in question.

---

(1)  OJ C 251, 09.10.2004.

1

---
# Croatia

79 items

        -    Report  		2019 Country Reports on Human Rights Practices: Croatia	  March 11, 2020 
        -    TIAS  		Croatia (20-228) – Scientific and Technological Cooperation Agreement	  February 28, 2020 
        -    Report  		Croatia	  July 11, 2019 
        -    Depositary Actions - Treaty Affairs  		North Macedonia Protocol – Notification of Deposit of Instrument; Montenegro, Slovakia and Croatia, May 23, 2019	   
        -    Report  		Croatia	  June 21, 2019 
        -    Report  		Croatia	  June 20, 2019 
        -    		Croatia	  April 23, 2019 
        -    		Durable Solutions	   
        -    Report  		Croatia	  March 13, 2019 
        -    TIAS  		Croatia (18-919.1) – Arrangement for the Exchange of Technical Information and Cooperation in Nuclear Safety Matters	  September 19, 2018 

previous page1…45678next page

Back to Top
<TABLE> <S> <C>

        <S> <C>
<ARTICLE> 5
<LEGEND>
                This schecdule contains summary financial information
                extracted from form 10-Q for this period ended
                March 31, 1997 and is qualified in its entirety
                by reference to such form 10-Q.

</LEGEND> 
<MULTIPLIER> 1

<S>                                <C> 
<PERIOD-TYPE>                      3-MOS 
<FISCAL-YEAR-END>                  JUN-30-1997 
<PERIOD-END>                       MAR-31-1997 
<CASH>                                       0
<SECURITIES>                                 0 
<RECEIVABLES>                                0
<ALLOWANCES>                                 0 
<INVENTORY>                                  0  
<CURRENT-ASSETS>                             0
<PP&E>                                       0 
<DEPRECIATION>                               0 
<TOTAL-ASSETS>                               0 
<CURRENT-LIABILITIES>                  107,082 
<BONDS>                                      0
<PREFERRED-MANDATORY>                        0 
<PREFERRED>                                  0
<COMMON>                                 3,505 
<OTHER-SE>                                   0 
<TOTAL-LIABILITY-AND-EQUITY>                 0
<SALES>                                      0 
<TOTAL-REVENUES>                             0 
<CGS>                                        0 
<TOTAL-COSTS>                                0   
<OTHER-EXPENSES>                         1,319  
<LOSS-PROVISION>                             0 
<INTEREST-EXPENSE>                           0
<INCOME-PRETAX>                         (1,319) 
<INCOME-TAX>                                 0 
<INCOME-CONTINUING>                     (1,319) 
<DISCONTINUED>                               0 
<EXTRAORDINARY>                              0
<CHANGES>                                    0 
<NET-INCOME>                            (1,319) 
<EPS-PRIMARY>                             (.00)
<EPS-DILUTED>                             (.00)


         

</TABLE>
§ 1005.9 Subpoenas for attendance at hearing. ( a ) A party wishing to procure the appearance and testimony of any individual at the hearing may make a motion requesting the ALJ to issue a subpoena if the appearance and testimony are reasonably necessary for the presentation of a party's case.
( b ) A subpoena requiring the attendance of an individual in accordance with paragraph (a) of this section may also require the individual (whether or not the individual is a party) to produce evidence authorized under § 1005.7 of this part at or prior to the hearing.
( c ) When a subpoena is served by a respondent or petitioner on a particular individual or particular office of the OIG, the OIG may comply by designating any of its representatives to appear and testify.
( d ) A party seeking a subpoena will file a written motion not less than 30 days before the date fixed for the hearing, unless otherwise allowed by the ALJ for good cause shown. Such request will: ( 1 ) Specify any evidence to be produced,
( 2 ) Designate the witnesses, and
( 3 ) Describe the address and location with sufficient particularity to permit such witnesses to be found.
( e ) The subpoena will specify the time and place at which the witness is to appear and any evidence the witness is to produce.
( f ) Within 15 days after the written motion requesting issuance of a subpoena is served, any party may file an opposition or other response.
( g ) If the motion requesting issuance of a subpoena is granted, the party seeking the subpoena will serve it by delivery to the individual named, or by certified mail addressed to such individual at his or her last dwelling place or principal place of business.
( h ) The individual to whom the subpoena is directed may file with the ALJ a motion to quash the subpoena within 10 days after service.
( i ) The exclusive remedy for contumacy by, or refusal to obey a subpoena duly served upon, any person is specified in section 205(e) of the Social Security Act (42 U.S.C. 405(e)).
[57 FR 3350, Jan. 29, 1992, as amended at 65 FR 24418, Apr. 26, 2000]
# C_2005171EN.01000101.xml

| 9.7.2005 | EN | Official Journal of the European Union | C 171/1 |
| --- | --- | --- | --- |

9.7.2005

EN

Official Journal of the European Union

C 171/1

---

JUDGMENT OF THE COURT

JUDGMENT OF THE COURT

(Grand Chamber)

of 10 May 2005

in Case C-400/99: Italian Republic v Commission of the European Communities (1)

1

(Action for annulment - State aid - Measures regarding maritime transport undertakings - Public service contracts - No aid, existing aid or new aid - Initiation of the procedure under Article 88(2) EC - Obligation to suspend)

(2005/C 171/01)

Language of the case: Italian

In Case C-400/99: Italian Republic (Agents: U. Leanza, I. Braguglia assisted by P.G. Ferri and M. Fiorilli) v Commission of the European Communities (Agents: E. De Persio, D. Triantafyllou and V. Di Bucci) — Action for annulment under Article 230 EC, brought on 18 October 1999 — the Court (Grand Chamber), composed of V. Skouris, President, P. Jann, C.W.A. Timmermans and A. Rosas, Presidents of Chambers, J.-P. Puissochet (Rapporteur), R. Schintgen, N. Colneric, S. von Bahr and J. N. Cunha Rodrigues, Judges; C. Stix-Hackl, Advocate General; R. Grass, Registrar, gave a judgment on 10 May 2005, in which it:

| 1. | Annuls the Commission decision, notified to the Italian authorities by letter SG(99) D/6463, of 6 August 1999, to initiate the procedure under Article 88(2) EC concerning State aid C 64/99 (ex NN 68/99) to the extent to which it entailed, until notification to the Italian authorities of the decision closing the procedure in relation to the undertaking concerned (Commission Decision C(2001) 1684 of 21 June 2001 or Commission Decision C(2004) 470 final of 16 March 2004) suspension of the tax treatment applied for the supply of fuel and lubricating oil to the vessels of Gruppo Tirrenia di Navigazione; |
| --- | --- |

1.

Annuls the Commission decision, notified to the Italian authorities by letter SG(99) D/6463, of 6 August 1999, to initiate the procedure under Article 88(2) EC concerning State aid C 64/99 (ex NN 68/99) to the extent to which it entailed, until notification to the Italian authorities of the decision closing the procedure in relation to the undertaking concerned (Commission Decision C(2001) 1684 of 21 June 2001 or Commission Decision C(2004) 470 final of 16 March 2004) suspension of the tax treatment applied for the supply of fuel and lubricating oil to the vessels of Gruppo Tirrenia di Navigazione;

| 2. | For the rest, dismisses the application; |
| --- | --- |

2.

For the rest, dismisses the application;

| 3. | Orders the parties to bear their own costs. |
| --- | --- |

3.

Orders the parties to bear their own costs.

---

(1)  OJ C 20 of 22.01.2000.

1

---
### UNITED STATES NAVY

- MARINE CORPS

COURT OF CRIMINAL APPEALS

WASHINGTON, D.C.

Before

F.D. MITCHELL, K.J. BRUBAKER, K.M. MCDONALD

Appellate Military Judges

UNITED STATES OF AMERICA

v.

EDWARD E. MARTIN

MACHINIST'S MATE FIRST CLASS (E

- 6), U.S. N A VY

NMCCA 201400323

GENERAL COURT

- MARTIAL

**Sentence Adjudged:** 15 May 2014

. **Military Judge:** Capt Robert B. Blazewick, JAGC, USN

. **Convening Authority:** Commander, Navy Region Southeast,

Naval Air Station, Jacksonville, Fl

. **Staff Judge Advocate's Recommendati on:**  CDR N.O. Evans,

JAGC, USN

. **For Appellant:** Capt David A. Peters, USMC.

**For Appellee:** Mr. Brian K. Keller , Esq

.

**21 May 2015** 

**---------------------------------------------------**

**OPINION OF THE COURT**

**------------------------------------------------- --** 

After careful consideration of the record, submitted

without assignment of error, we affirm the findings and sentence

as approved by the convening authority. Art. 66(c), Uniform

Code of Military Justice, 10 U.S.C. § 866(c).

For the Court

R.H. TROIDL

Clerk of Court
Exhibit 31.2

                           Section 302 Certifications

I, Richard Bruggeman, certify that:

         1. I have  reviewed  this  quarterly  report on form 10-QSB of InMedica
Development Corporation.

         2. Based on my knowledge,  this  quarterly  report does not contain any
untrue  statement of a material fact or omit to state a material fact  necessary
to make the  statements  made,  in light of the  circumstances  under which such
statements  were made, not misleading with respect to the period covered by this
quarterly report.

         3. Based on my knowledge, the financial statements, and other financial
information  included in this quarterly  report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

         4.  I  am  responsible  for  establishing  and  maintaining  disclosure
controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for
the registrant and have:

         a) Designed  such  disclosure  controls and  procedures  to ensure that
material  information  relating to the  registrant,  including its  consolidated
subsidiaries, is made known to us by others within those entities,  particularly
during the period in which this quarterly report is being prepared.

         b) Evaluated the effectiveness of the registrant's  disclosure controls
and  procedures  as of a date  within 90 days prior to the  filing  date of this
quarterly report (the "Evaluation Date"); and

         c)  Presented  in this  quarterly  report  our  conclusions  about  the
effectiveness of the disclosure  controls and procedures based on our evaluation
as of the Evaluation Date;

         5. I have  disclosed,  based  on our  most  recent  evaluation,  to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

         a) All significant  deficiencies in the design or operation of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and have  identified  for the
registrant's auditors any material weaknesses in internal controls; and

         b) Any fraud,  whether or not  material,  that  involves  management or
other  employees  who  have a  significant  role  in the  registrant's  internal
controls; and

Date:  August 12, 2003

By: /s/ Richard Bruggeman
Richard Bruggeman, CFO
#### Joseph SELPH, Appellant, v. Christopher John VANN et al., Appellees.

No. 74-1632.

District Court of Appeal of Florida, Fourth District.

Feb. 4, 1975.

Appeal dismissed.